SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Nymox Pharmaceautical Corporation
NYMXF 0.106-0.9%10:45 AM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Apple Jacks who wrote (21)3/19/1998 1:01:00 PM
From: Henry Zurowski  Read Replies (1) of 28
 
Look at these names on the board of Directors, apple Jack:

Dr Carl Merrill, (of the NIMH and recipient of many honours)

Dr Leslie Iversen (of Oxford Uinversity)

Dr J Kenneth Harrington (30+ years of experience in the field)

If it's true as you say that you work in the industry then you would know these are renowned and respected names in the AD field.
Why would they join NYMOX if the science was suspect?
To make a quick buck? I think not.

You say they are secretive, well have you heard of what went down on Monday in NYC? Dr Averbakh (CEO) gave a stunning presentation - why do you think the stock doubled on Monday? Neurologists and people in the know were buying. If it retreated Tuesday and Wednesday you might
say technically it's a normal retracement, aided and abetted by uninformed and just plain stupid rumour-mongering by short-sellers.

NYMOX claims not just to have a diagnostic, but can explain the development of AD in the human brain. It's years ahead of it's
competitors.

Have you read the paper in the Journal of Clinical Investigation?
Have you visted the NYMOX homepage? What 'facts' do you really know?
Have you checked the patents?

Better still: are you short the stock?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext